Skip to content

Beam Therapeutics

US · BEAM #2614 by market cap Listed 2020
24.77 -0.46 -1.82%
Live - 5344 symbols - heartbeat 524s ago · 2026-10-08 06:33
Pre-market 24.25 -2.10%
After-hours 25.00 +0.91%
Overnight 24.72 -0.20%
Market cap
2.56B
P/B
2.40
EPS
-0.81
Reader sentiment Are you bullish or bearish on BEAM?

Anonymous reader poll. Unscientific, not investment advice.

Beam Therapeutics shares were changing hands at 24.77, down 1.82% on the day. The company carries a market value of roughly 2.56B, the #2614 most valuable US-listed company we track. Across 9 analysts the consensus rating is Buy, with an average price target of 53.38 (+116%). Against a 52-week band of 20.23-38.26, the shares are currently 25% of the way up.

✦ StockVane Quant Insights how this is computed

Quant Rating D Sell
  • Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
  • Signal has read SELL for 4 weeks.
See the full rating history & follow-along return →
Quant Sentiment Neutral
  • Recent price momentum is -18.1% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 25.1% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Neutral
  • Price is above its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Price chart

37.9223.1024.772026-04-092026-10-07
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60

Performance

1W +1.31%
1M -16.49%
3M -34.68%
6M +1.14%
YTD -10.64%
1Y -1.43%
3Y +15.59%
5Y -70.85%

Key statistics

Price & volume

Prev close
25.23
Open
24.64
Day range
24.45 - 25.37
Avg price
24.83
Volume
2.34M
Turnover
58.17M
Amplitude
3.65%
52-week range
20.23 - 38.26

Valuation

P/E
-30.58
P/E (TTM)
-35.90
P/B
2.40
EPS
-0.81
Net profit
-83.66M
Net assets
1.07B

Share structure

Market cap
2.56B
Float cap
2.27B
Shares out
103.29M
Float shares
91.69M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2020-02-06
52-week range 25% of range
20.23 38.26

35.3% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-2.98M net over the window

Short interest

Shares short
25.88M
As of
2026-09-15

Frequently asked questions

What is the current stock price of Beam Therapeutics (BEAM)?

Beam Therapeutics last traded at 24.77. The quote on this page refreshes every few seconds while US markets are open.

What is Beam Therapeutics's market cap?

About 2.56B.

What is the P/E ratio of Beam Therapeutics?

The trailing twelve-month P/E is -35.90. The Valuation tab shows it against the stock's own five-year range.

Does Beam Therapeutics pay a dividend?

Beam Therapeutics does not currently pay a regular dividend.

Is Beam Therapeutics a buy according to analysts?

The consensus of 9 analysts is a Buy rating, with an average 12-month price target of 53.38, which implies 115.5% upside from the current price. This is not investment advice.

What is Beam Therapeutics's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Beam Therapeutics a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.

Quote time 2026-10-08 06:33:39 · For reference only, not investment advice and not tailored to your situation.